Steven Cohen’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.2M Sell
136,793
-101,034
-42% -$2.23M ﹤0.01% 2359
2026
Q2
$7.9M Sell
237,827
-454,284
-66% -$14.2M 0.01% 1432
2026
Q1
$17.2M Buy
692,111
+513,023
+286% +$9.27M 0.02% 887
2025
Q4
$2.07M Buy
+179,088
New +$1.7M ﹤0.01% 2449
2025
Q1
– Sell
-219,754
Closed -$4.04M – 2514
2024
Q4
$4.04M Sell
219,754
-79,991
-27% -$2.44M 0.01% 1020
2024
Q3
$10.4M Sell
299,745
-145,018
-33% -$5.68M 0.03% 635
2024
Q2
$13M Buy
444,763
+418,693
+1,606% +$16.6M 0.03% 520
2024
Q1
$1.47M Sell
26,070
-2,500
-9% -$110K ﹤0.01% 1364
2023
Q4
$1.23M Sell
28,570
-24,745
-46% -$785K ﹤0.01% 1345
2023
Q3
$1.85M Buy
53,315
+32,415
+155% +$1.41M 0.01% 1151
2023
Q2
$972K Buy
+20,900
New +$1.04M ﹤0.01% 1147
2023
Q1
– Sell
-79,060
Closed -$6.39M – 2529
2022
Q4
$6.39M Buy
79,060
+7,960
+11% +$553K 0.02% 685
2022
Q3
$3.95M Buy
+71,100
New +$4.21M 0.02% 786
2021
Q4
– Sell
-37,500
Closed -$7.08M – 1291
2021
Q3
$7.08M Sell
37,500
-76,160
-67% -$14.5M 0.03% 578
2021
Q2
$21.1M Buy
113,660
+17,840
+19% +$3.49M 0.09% 274
2021
Q1
$21.8M Sell
95,820
-45,111
-32% -$10.7M 0.1% 244
2020
Q4
$30.6M Buy
140,931
+39,881
+39% +$6.6M 0.15% 189
2020
Q3
$10.2M Buy
101,050
+41,050
+68% +$3.88M 0.05% 402
2020
Q2
$4.66M Buy
+60,000
New +$5.76M 0.03% 495
2019
Q3
– Sell
-32,238
Closed -$3.67M – 1450
2019
Q2
$3.67M Buy
+32,238
New +$3.55M 0.02% 570

Other funds holding STRO

Steven Cohen's STRO Position: Q3 2026 in Review

Steven Cohen reduced its Sutro Biopharma (STRO) stake by 42% in Q3 2026, selling an estimated $2.23M and leaving 136,793 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

Steven Cohen first reported a position in STRO in Q2 2019 and has held it in 20 quarters since. The position peaked at $30.6M in Q4 2020. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Steven Cohen held 136,793 shares of Sutro Biopharma worth $2.2M as of Q3 2026.
  • Steven Cohen sold 101,034 Sutro Biopharma shares in Q3 2026, an estimated $2.23M.
  • Sutro Biopharma made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2359 holding.
  • Steven Cohen first reported a position in Sutro Biopharma in Q2 2019 and has held it in 20 quarters since.
  • Steven Cohen's Sutro Biopharma position peaked at $30.6M in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.